176 related articles for article (PubMed ID: 29268568)
1. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
Shin SJ; Park H; Sung YN; Yoo C; Hwang DW; Park JH; Kim KP; Lee SS; Ryoo BY; Seo DW; Kim SC; Hong SM
Cancer Res Treat; 2018 Oct; 50(4):1175-1185. PubMed ID: 29268568
[TBL] [Abstract][Full Text] [Related]
2. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases.
Eriguchi N; Aoyagi S; Hara M; Okuda K; Tamae T; Fukuda S; Hashino K; Sato S; Fujiki K; Furukawa S; Jimi A
Surg Today; 2000; 30(8):718-21. PubMed ID: 10955735
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
[TBL] [Abstract][Full Text] [Related]
4. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Dis Colon Rectum; 2000 Aug; 43(8):1093-9. PubMed ID: 10950007
[TBL] [Abstract][Full Text] [Related]
5. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
6. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study.
Tanjak P; Suktitipat B; Vorasan N; Juengwiwattanakitti P; Thiengtrong B; Songjang C; Therasakvichya S; Laiteerapong S; Chinswangwatanakul V
BMC Cancer; 2021 Sep; 21(1):1045. PubMed ID: 34556087
[TBL] [Abstract][Full Text] [Related]
7. Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance.
Lee WS; Lee JN; Choi S; Jung M; Baek JH; Lee WK
Langenbecks Arch Surg; 2010 Apr; 395(4):359-64. PubMed ID: 19763603
[TBL] [Abstract][Full Text] [Related]
8. High incidence combination of multiple primary malignant tumors of the digestive system.
Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110
[TBL] [Abstract][Full Text] [Related]
9. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.
Lee J; Park S; Kim S; Kim J; Ryu J; Park HS; Kim SI; Park BW
Yonsei Med J; 2015 Sep; 56(5):1213-20. PubMed ID: 26256962
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
13. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
14. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients.
Jiang Y; Miao Z; Wang J; Chen J; Lv Y; Xing D; Wang X; Wang Y; Cao Z; Zhao Z
Tumori; 2019 Dec; 105(6):474-482. PubMed ID: 30945608
[TBL] [Abstract][Full Text] [Related]
16. Multiple primary lung cancers.
Ribet M; Dambron P
Eur J Cardiothorac Surg; 1995; 9(5):231-6. PubMed ID: 7662375
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis.
Fujita Y; Matsuda S; Sasaki Y; Masugi Y; Kitago M; Yagi H; Abe Y; Shinoda M; Tokino T; Sakamoto M; Kitagawa Y
Cancer Sci; 2020 Feb; 111(2):739-748. PubMed ID: 31799787
[TBL] [Abstract][Full Text] [Related]
18. Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study.
Ławniczak M; Gawin A; Jaroszewicz-Heigelmann H; Rogoza-Mateja W; Raszeja-Wyszomirska J; Białek A; Karpińska-Kaczmarczyk K; Starzyńska T
World J Gastroenterol; 2014 Jun; 20(23):7480-7. PubMed ID: 24966619
[TBL] [Abstract][Full Text] [Related]
19. The results of modern surgical therapy for multiple primary lung cancers.
Adebonojo SA; Moritz DM; Danby CA
Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
[TBL] [Abstract][Full Text] [Related]
20. Multiple primary lung carcinomas: prognosis and treatment.
Rosengart TK; Martini N; Ghosn P; Burt M
Ann Thorac Surg; 1991 Oct; 52(4):773-8; discussion 778-9. PubMed ID: 1929628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
